Physician profile
Fernando E Bayron Velez
NPI 1891783080
$45,404.38
in general payments reported to CMS, 2019-2025
33 companies · $2,646 in 2025
The $2,646 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $6,709 · 2021: $5,381 · 2022: $1,370 · 2023: $10K · 2024: $1,256 · 2025: $2,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $4,486 · Travel and Lodging: $1,499 · Gift: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $4,485.61 |
| Travel and Lodging | $1,498.87 |
| Gift | $177.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38,207.75 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $2,265.66 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Biotissue Holdings INC. | $1,102.97 | 2021-2025 | |
| Medical Device Business Services, INC. | $918.34 | 2019-2021 | |
| Novo Nordisk INC | $568.96 | 2022-2025 | Wegovy, Saxenda |
| Ethicon US, LLC | $431.62 | 2019-2022 | |
| Davol INC. | $354.83 | 2019-2024 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $250.33 | 2023-2025 | |
| Integra Lifesciences Corporation | $142.56 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Acell, INC. | $124.80 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $115.12 | 2025 | |
| Medtronic, INC. | $107.12 | 2022-2025 | Ligasure, Signia |
| Organogenesis INC. | $93.47 | 2022-2023 | Puraply |
| Smith+Nephew, INC. | $74.28 | 2021-2023 | Grafix Pl |
| Kowa Pharmaceuticals America, INC. | $67.06 | 2022-2023 | Seglentis |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $56.51 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.31 | 2023 | Gattex |
| Abbott Laboratories | $48.68 | 2021 | |
| Polynovo North America LLC | $42.59 | 2025 | Novosorb Btm |
| Endo Pharmaceuticals INC. | $39.27 | 2022-2023 | Nascobal |
| Acera Surgical, INC. | $38.10 | 2023-2024 | Restrata Wound Matrix |
| Teleflex LLC | $34.23 | 2024 | Titan Sgs |
| Osiris Therapeutics INC. | $34.00 | 2019 | |
| Access Pro Medical, LLC | $31.39 | 2025 | Matriderm |
| Bioventus LLC | $30.12 | 2022 | |
| Hologic Sales and Service, LLC | $29.84 | 2023 | Coolseal Generator |
| Intra-Sana Laboratories | $29.35 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Lilly USA, LLC | $29.27 | 2025 | Zepbound |
| Leica Microsystems INC. | $22.34 | 2022 | |
| Conmed Corporation | $20.21 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $16.98 | 2023 | Lynparza, Keytruda |
| Lexington Medical, INC. | $13.98 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Allergan, INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Bayron Velez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.